Gustavo E. Velásquez

958 total citations
26 papers, 403 citations indexed

About

Gustavo E. Velásquez is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Gustavo E. Velásquez has authored 26 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 16 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in Gustavo E. Velásquez's work include Tuberculosis Research and Epidemiology (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Mycobacterium research and diagnosis (6 papers). Gustavo E. Velásquez is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers) and Mycobacterium research and diagnosis (6 papers). Gustavo E. Velásquez collaborates with scholars based in United States, Peru and United Kingdom. Gustavo E. Velásquez's co-authors include Carole D. Mitnick, Leonid Lecca, Róger Calderón, Megan Murray, Karen Tintaya, Judith Jiménez, Geraint Davies, Julia Coit, Dante Vargas Vásquez and Charles A. Peloquin and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Gustavo E. Velásquez

25 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gustavo E. Velásquez United States	11	303	227	74	35	29	26	403
Caleb P Skipper United States	12	365 1.2×	327 1.4×	30 0.4×	42 1.2×	25 0.9×	37	559
Giacomo Casalini Italy	12	334 1.1×	164 0.7×	22 0.3×	60 1.7×	30 1.0×	27	520
Matt Oliver United States	4	250 0.8×	195 0.9×	92 1.2×	83 2.4×	10 0.3×	6	419
Christopher D. Doern United States	11	90 0.3×	95 0.4×	67 0.9×	49 1.4×	26 0.9×	22	323
Francis Mumbowa Uganda	11	410 1.4×	381 1.7×	135 1.8×	51 1.5×	14 0.5×	15	515
Carl Reddy South Africa	9	474 1.6×	379 1.7×	129 1.7×	117 3.3×	38 1.3×	15	602
Marios Lazanas Greece	9	150 0.5×	158 0.7×	26 0.4×	36 1.0×	18 0.6×	23	374
Denise Dunbar United States	8	389 1.3×	404 1.8×	116 1.6×	52 1.5×	10 0.3×	11	500
Harika Öykü Dinç Türkiye	10	134 0.4×	47 0.2×	51 0.7×	48 1.4×	14 0.5×	54	301
Folusakin Ayoade United States	7	144 0.5×	95 0.4×	18 0.2×	23 0.7×	16 0.6×	27	268

Countries citing papers authored by Gustavo E. Velásquez

Since Specialization

Citations

This map shows the geographic impact of Gustavo E. Velásquez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo E. Velásquez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo E. Velásquez more than expected).

Fields of papers citing papers by Gustavo E. Velásquez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gustavo E. Velásquez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo E. Velásquez. The network helps show where Gustavo E. Velásquez may publish in the future.

Co-authorship network of co-authors of Gustavo E. Velásquez

This figure shows the co-authorship network connecting the top 25 collaborators of Gustavo E. Velásquez. A scholar is included among the top collaborators of Gustavo E. Velásquez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gustavo E. Velásquez. Gustavo E. Velásquez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Platt, Georgina, Charles A. Peloquin, Julia Coit, et al.. (2025). Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial. The Journal of Infectious Diseases. 232(2). e258–e265.

Louie, Janice K., et al.. (2024). Experience With Four-Month Rifapentine and Moxifloxacin–Based Tuberculosis Treatment in San Francisco. Open Forum Infectious Diseases. 11(4). ofae178–ofae178. 8 indexed citations

Law, Stephanie, Marco Tovar, Molly F. Franke, et al.. (2023). Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru. BMC Infectious Diseases. 23(1). 62–62. 1 indexed citations

Motta, Ilaria, Martin J. Boeree, Dumitru Chesov, et al.. (2023). Recent advances in the treatment of tuberculosis. Clinical Microbiology and Infection. 30(9). 1107–1114. 49 indexed citations

Jhaveri, Tulip A., Chengbo Zeng, Rifat Rahman, et al.. (2022). Clinical Outcomes of Individuals with COVID-19 and Tuberculosis during the Pre-Vaccination Period of the Pandemic: A Systematic Review. Journal of Clinical Medicine. 11(19). 5656–5656. 7 indexed citations

Tovar, Marco, Jesús Peinado, Róger Calderón, et al.. (2021). Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies Among Market and City Bus Depot Workers in Lima, Peru. Clinical Infectious Diseases. 74(2). 343–346. 3 indexed citations

Richterman, Aaron, Samuel J. Vidal, Zoe Weiss, et al.. (2020). Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series. Open Forum Infectious Diseases. 7(10). 32 indexed citations

Rahman, Rifat, Amir M. Mohareb, Nirav J. Patel, et al.. (2020). Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case Report. Open Forum Infectious Diseases. 7(4). ofaa077–ofaa077. 6 indexed citations

Velásquez, Gustavo E., Meredith B. Brooks, Julia Coit, et al.. (2018). Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 198(5). 657–666. 74 indexed citations

10.

Jain, Nina, Jeffrey B. Doyon, Jacob E. Lazarus, et al.. (2018). A Case of Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis on Abatacept. Journal of General Internal Medicine. 33(5). 769–772. 7 indexed citations

11.

Peloquin, Charles A., Gustavo E. Velásquez, Leonid Lecca, et al.. (2017). Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis. Antimicrobial Agents and Chemotherapy. 61(8). 28 indexed citations

12.

Calderón, Róger, Gustavo E. Velásquez, M. C. Becerra, et al.. (2017). Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru. The International Journal of Tuberculosis and Lung Disease. 21(8). 894–901. 8 indexed citations

13.

Velásquez, Gustavo E., et al.. (2016). Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model. PLoS neglected tropical diseases. 10(8). e0004866–e0004866. 4 indexed citations

14.

Aibana, Omowunmi, Chuan-Chin Huang, Mercedes C. Becerra, et al.. (2016). Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts. PLoS ONE. 11(11). e0166333–e0166333. 20 indexed citations

15.

Velásquez, Gustavo E., Róger Calderón, Carole D. Mitnick, et al.. (2016). Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 60(11). 6766–6773. 11 indexed citations

16.

Velásquez, Gustavo E., J. Peter Cegielski, Megan Murray, et al.. (2015). Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study. BMC Infectious Diseases. 16(1). 45–45. 5 indexed citations

17.

Velásquez, Gustavo E., et al.. (2015). Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review. Clinical Infectious Diseases. 61(7). 1135–1140. 31 indexed citations

18.

Velásquez, Gustavo E., M. C. Becerra, Irina Gelmanova, et al.. (2014). Improving Outcomes for Multidrug-Resistant Tuberculosis: Aggressive Regimens Prevent Treatment Failure and Death. Clinical Infectious Diseases. 59(1). 9–15. 41 indexed citations

19.

Velásquez, Gustavo E., Martín Yagui, J. Peter Cegielski, et al.. (2011). Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant Tuberculosis Detection, Lima, Peru, 2005–2008. Emerging infectious diseases. 17(3). 432–440. 18 indexed citations

20.

Rosner, Jorge M., Alicia Schinini, Antonieta Rojas de Árias, et al.. (1988). Acute Chagas' disease in non-human primates. 1. Chronology of clinical events, clinical chemistry, ECG, radiology, parasitemia, and immunological parameters in the Cebus apella monkey.. PubMed. 39(1). 51–5. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact